Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
Carmen Criscitiello, Andrea Vingiani, Patrick Maisonneuve, Giulia Viale, Giulia Viale, Giuseppe Curigliano
Topics & Concepts
MedicineInternal medicineOncologyTumor-infiltrating lymphocytesProportional hazards modelBreast cancerCohortUnivariate analysisPathologicalChemotherapyCancerGastroenterologyMultivariate analysisImmunotherapyCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisImmune cells in cancer